Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis CA Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

被引：0
|
作者：
Gaetano Scotto
Vincenzina Fazio
Chiara Fornabaio
Alessandra Tartaglia
Rocco Di Tullio
Annalisa Saracino
Gioacchino Angarano
机构：
[1] University of Foggia,Clinic of Infectious Diseases
[2] Hospital of Foggia,Clinical Chemistry Laboratory
来源：
Drugs | 2008年 / 68卷
关键词：
Viral Load; Sustained Virological Response; Early Virological Response; Viral Kinetic; Standard Interferon;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives: The purpose of this randomized open-label study was to assess the efficacy of treatment with pegylated interferon-α-2a versus pegylated interferon-α-2b, both plus ribavirin, in inducing early and sustained virological response (EVR and SVR) in chronic hepatitis C non-responders.
引用
收藏
页码：791 / 801
页数：10
相关论文
共 50 条
  • [41] Pegylated interferon-α2b for local control of Langerhans cell sarcoma
    Yosuke Ishitsuka
    Kazuma Iwamoto
    Kazumasa Oya
    Yoshiyuki Nakamura
    Rei Watanabe
    Naoko Okiyama
    Yasuhiro Fujisawa
    Manabu Fujimoto
    European Journal of Dermatology, 2018, 28 : 835 - 836
  • [42] End Treatment Response with Pegylated Interferon among Chronic Hepatitis C Non-Responders
    Shafi, Mohammad Shoaib
    Anjum, Jahangir
    Beg, Muhammad Atif
    Naseem, Sajida
    Manzoor, Shehzad
    Hussain, Tanveer
    Abbass, Syed Azmat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (06): : 334 - 337
  • [43] Pegylated interferon-α2b for local control of Langerhans cell sarcoma
    Ishitsuka, Yosuke
    Iwamoto, Kazuma
    Oya, Kazumasa
    Nakamura, Yoshiyuki
    Watanabe, Rei
    Okiyama, Naoko
    Fujisawa, Yasuhiro
    Fujimoto, Manabu
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (06) : 835 - 836
  • [44] Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4
    Shiha, G
    Gabre, M
    Zalata, K
    Sayed, S
    GUT, 2004, 53 : A81 - A81
  • [45] Induction therapy with interferon-α 2b associated to Ribavirin and Ketoprofen in patients with chronic hepatitis C non-responders to interferon.: A pilot study.
    Munoz, AE
    Levi, DV
    Miguez, CD
    Cisterna, D
    Terg, RA
    HEPATOLOGY, 2001, 34 (04) : 589A - 589A
  • [46] Pegylated interferon-α-2b for children with recurrent craniopharyngioma Clinical article
    Yeung, Jacky T.
    Pollack, Ian F.
    Panigrahy, Ashok
    Jakacki, Regina I.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2012, 10 (06) : 498 - 503
  • [47] Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C -: Comparison between interferon-α-2a and interferon-α-2b
    Neri, Sergio
    Pulvirenti, Davide
    Bertino, Gaetano
    CLINICAL DRUG INVESTIGATION, 2006, 26 (11) : 655 - 662
  • [48] Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia
    Baccarani, M
    Martinelli, G
    Rosti, G
    Trabacchi, E
    Testoni, N
    Bassi, S
    Amabile, M
    Soverini, S
    Castagnetti, F
    Cilloni, D
    Izzo, B
    de Vivo, A
    Messa, E
    Bonifazi, F
    Poerio, A
    Luatti, S
    Giugliano, E
    Alberti, D
    Fincato, G
    Russo, D
    Pane, F
    Saglio, G
    BLOOD, 2004, 104 (13) : 4245 - 4251
  • [49] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [50] A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
    Piccolo, Paola
    Lenci, Ilaria
    Demelia, Luigi
    Bandiera, Franco
    Piras, Maria R.
    Antonucci, Giorgio
    Nosotti, Lorenzo
    Mari, Terenzio
    De Santis, Adriano
    Ponti, Maria L.
    Sorbello, Orazio
    Iacomi, Fabio
    Angelico, Mario
    ANTIVIRAL THERAPY, 2009, 14 (08) : 1165 - 1174
12345